These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22488221)

  • 21. Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.
    da Silva Franco N; Lubaczeuski C; Guizoni DM; Victorio JA; Santos-Silva JC; Brum PC; Carneiro EM; Davel AP
    Pharmacol Res; 2017 Aug; 122():35-45. PubMed ID: 28539257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sympathetic nervous system in obesity hypertension.
    Lohmeier TE; Iliescu R
    Curr Hypertens Rep; 2013 Aug; 15(4):409-16. PubMed ID: 23677623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
    Cabandugama PK; Gardner MJ; Sowers JR
    Med Clin North Am; 2017 Jan; 101(1):129-137. PubMed ID: 27884224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.
    Barton M; Carmona R; Ortmann J; Krieger JE; Traupe T
    Int J Biochem Cell Biol; 2003 Jun; 35(6):826-37. PubMed ID: 12676169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
    Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
    Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.
    Manrique C; Lastra G; Gardner M; Sowers JR
    Med Clin North Am; 2009 May; 93(3):569-82. PubMed ID: 19427492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the obesity epidemic on hypertension and renal disease.
    Hall JE; Jones DW; Kuo JJ; da Silva A; Tallam LS; Liu J
    Curr Hypertens Rep; 2003 Oct; 5(5):386-92. PubMed ID: 12948431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
    Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
    Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.
    Balasubramanian P; Hall D; Subramanian M
    Geroscience; 2019 Feb; 41(1):13-24. PubMed ID: 30519806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
    Engeli S; Sharma AM
    Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and clinical physiology of hypertension.
    Singh M; Mensah GA; Bakris G
    Cardiol Clin; 2010 Nov; 28(4):545-59. PubMed ID: 20937440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is obesity a major cause of chronic kidney disease?
    Hall JE; Henegar JR; Dwyer TM; Liu J; Da Silva AA; Kuo JJ; Tallam L
    Adv Ren Replace Ther; 2004 Jan; 11(1):41-54. PubMed ID: 14730537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a rationale for angiotensin blockade in the management of obesity hypertension?
    Sharma AM
    Hypertension; 2004 Jul; 44(1):12-9. PubMed ID: 15173127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice.
    Huby AC; Otvos L; Belin de Chantemèle EJ
    Hypertension; 2016 May; 67(5):1020-8. PubMed ID: 26953321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and blood pressure.
    Addison S; Stas S; Hayden MR; Sowers JR
    Curr Hypertens Rep; 2008 Aug; 10(4):319-25. PubMed ID: 18625163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin and blood pressure regulation.
    Gans RO; Donker AJ
    J Intern Med Suppl; 1991; 735():49-64. PubMed ID: 2043223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of essential hypertension: an update.
    Saxena T; Ali AO; Saxena M
    Expert Rev Cardiovasc Ther; 2018 Dec; 16(12):879-887. PubMed ID: 30354851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.